Review article: Extraoesophageal manifestations of gastro-oesophageal reflux disease

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 22, Issue 1, 2005, Pages 70-80

  Richter, J E ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRONCHODILATING AGENT; ESOMEPRAZOLE; HISTAMINE H2 RECEPTOR ANTAGONIST; LANSOPRAZOLE; PLACEBO; PROKINETIC AGENT; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; STEROID;

ALGORITHM; ASTHMA; CLINICAL FEATURE; COUGHING; DIAGNOSTIC TEST; EAR NOSE THROAT DISEASE; ESOPHAGUS PH; GASTROESOPHAGEAL REFLUX; HUMAN; LARYNGOSCOPY; LUNG DISEASE; LUNG FIBROSIS; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME;

EID: 23844452717     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2005.02613.x     Document Type: Review

References (51)

1. Richter JE. Extraoesophageal presentations of gastro-esophageal reflux disease: an overview. Am J Gastroenterol 2000; 95 (Suppl.): S1-3.
2. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
3. El-Serag HB, Sonnenberg A. Co-morbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997; 113: 755-60.
4. Jaspersen D, Kulig M, Labenz J, et al. Prevalence of extraoesophageal manifestations in gastroesophageal reflux disease: an analysis based on the ProGERD Study. Aliment Pharmacol Ther 2003; 17: 1515-20.
5. Vaezi MF, Hicks DM, Abelson TI, Richter JE. Laryngeal signs and symptoms and gastroesophageal reflux disease: a critical assessment of cause and effect association. Clin Gastroenterol Hepatol 2003; 1: 333-44.
6. Koufman JA. The otolaryngologic manifestation of gastroesophageal reflux disease. Laryngoscope 1991; 101: 1-78.
7. Vaezi MF, Richter JE. Role of acid and duodenogastroesophageal reflux disease. Gastroenterology 1996; 111: 1192-9.
8. Tutuian R, Vela MF, Shay SS, Castell DO. Multichannel intraluminal impedance in esophageal function testing and gastroesophageal reflux monitoring. J Clin Gastroenterol 2003; 37: 206-15.
9. Adhami T, Goldblum JR, Richter JE, Vaezi MF. The role of gastric and duodenal agents in laryngeal injury: an experimental canine model. Am J Gastroenterol 2004; 99: 2098-106.
10. Hicks DM, Ours TM, Abelson TI, et al. The prevalence of hypopharyngeal findings associated with gastroesophageal reflux in normal volunteers. J Voice 2002; 16: 564-79.
11. Branski RC, Bhattacharya N, Shapiro J. The reliability of the assessment of endoscopic laryngeal findings associated with laryngopharyngeal reflux disease. Laryngoscope 2002; 112: 1019-24.
12. Eubanks TR, Omelanczak PE, Masonian N, et al. Pharyngeal pH monitoring in 222 patients with suspected laryngeal reflux. J Gastrointest Surg 2001; 5: 183-91.
13. Noordzij JP, Khidir A, Desper E, et al. Correlation of pH probe measured laryngopharyngeal reflux with symptoms and signs of reflux laryngitis. Laryngoscope 2002; 112: 2192-5.
14. Powitzkey ES, Khaitan L, Richards WO, et al. Symptoms, quality of life, videolaryngoscopy and 24 hour triple probe pH monitoring in patients with typical and extraoesophageal reflex. Ann Otol Rhinol Laryngol 2003; 112: 859-65.
15. Oelschlagor BK, Eubanks TR, Masonian N, et al. Laryngoscopy and pharyngeal pH are complementary in the diagnosis of gastroesophageal-laryngeal reflux. J Gastrointest Surg 2002; 6: 189-94.
16. Williams RB, Ali GN, Wallace KI, et al. Esophagopharyngeal acid regurgitation: dual pH monitoring criteria for its detection and insight into mechanisms. Gastroenterology 1999; 117: 1051-61.
17. Wo JM, Jabbar A, Winstead W, et al. Hypopharyngeal pH monitoring artifact in detection of laryngopharyngeal reflux. Dig Dis Sci 2002; 47: 2579-85.
18. Shaker R, Milbroth M, Ren J, et al. Esophagopharyngeal distribution of refluxed gastric acid in patients with reflux laryngitis. Gastroenterology 1995; 109: 1575-82.
19. Shaker R, Bardan E, Gu C, et al. Intrapharyngeal distribution of gastric acid refluxate. Laryngoscope 2003; 113: 1182-91.
20. Ulualp SO, Toohill RJ, Shaker R. Outcome of acid suppressive therapy in patients with posterior laryngitis. Otolaryngol Head Neck Surg 2001; 124: 16-22.
21. Noordzij JP, Khidr A, Evans BA, et al. Evaluation of omeprazole in the treatment of reflux laryngitis: a prospective, placebo-controlled, randomized, double-blind study. Laryngoscope 2001; 111: 2147-51.
22. Vaezi MF, Charbel S. On-therapy pH monitoring: usually recommended but should we do it? Gastroenterology 2004; A82.
23. El-Serag HB, Lee P, Buchner A, et al. Lansoprazole treatment of patients with chronic idiopathic laryngitis: a placebo-controlled trial. Am J Gastroenterol 2001; 96: 979-83.
24. Havas T, Huang S, Levy M, et al. Posterior pharyngolaryngitis. Double-blind randomized placebo-controlled trial of proton pump inhibitor therapy. Aust J Otolaryngol 1999; 3: 243-6.
25. Eherer AJ, Habermann W, Hammer HF, et al. Effect of pantoprazole on the course of reflux-associated laryngitis: a placebo-controlled double-blind crossover study. Scand J Gastroenterol 2003; 38: 462-7.
26. Vaezi MF, Richter JE, Stasney R, et al. A randomized double-blind placebo controlled study of acid suppression for the treatment of suspected laryngopharyngeal reflux. Gastroenterology 2004; 126: A22.
27. Richter JE, Vaezi MF, Stasney R, et al. Baseline pH measurements for patients with suspected signs and symptoms of reflux laryngitis. Gastroenterology 2004; 126: A537.
28. Harding SM, Sontag SJ. Asthma and gastroesophageal reflux. Am J Gastroenterol 2000; 95 (Suppl.): 523-32.
29. Irwin RS, Curley FJ, French CL. Difficult-to-control asthma: contributing factors and outcome of a systematic protocol. Chest 1993; 103: 1662-9.
30. Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 2000; 162: 34-9.
31. Liou A, Grubb JR, Schechtman KB, Hamilos DL. Causative and contributive factors to asthma severity and patterns of medication use in patients seeking specialized asthma care. Chest 2003; 124: 1781-8.
32. Irwin RS, Richter JE. Gastroesophageal reflux and chronic cough. Am J Gastroenterol 2000; 95 (Suppl.): S8-S14.
33. Irwin RS, Boulet LP, Cloutier MM, et al. Managing cough as a defense mechanism and as a symptom: a consensus panel report of the American College of Chest Physicians. Chest 1998; 114 (Suppl.): 133S-81S.
34. May EE, Dubois JJ, Hamilton GB. Pulmonary fibrosis associated with tracheobronchial aspiration. Chest 1976; 69: 512-5.
35. Tobin RW, Pope CE, Pellegrini CA, et al. Increased prevalence of gastroesophageal reflux in patients with idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998; 158: 1804-8.
36. Wright RA, Miller SA, Corsello BE. Acid-induced esophagobronchial cardiac reflex in humans. Gastroenterology 1990; 99: 71-3.
37. Schan CA, Harding SM, Haile JM, Bradley LA, Richter JE. Gastroesophageal reflux-induced bronchoconstriction: an intraesophageal acid infusion study using state-of-the-art technology. Chest 1994; 106: 731-7.
38. Tuchman DN, Boyle JT, Pack AI, et al. Comparison of airway responses following tracheal or esophageal acidification in the cat. Gastroenterology 1984; 87: 872-81.
39. Connelly RJ, Berrisford RG, Jack CI, et al. Simultaneous tracheal and esophageal pH monitoring: investigating reflux-associated asthma. Ann Thorac Surg 1993; 56: 1029-34.
40. Sontag SJ, Schnell TG, Miller TQ, et al. Prevalence of oesophagitis in asthmatics. Gut 1992; 61: 872-6.
41. Irwin RS, French CL, Curley FJ, et al. Chronic cough due to gastroesophageal reflux. Clinical, diagnostic and pathogenic aspects. Chest 1993; 104: 1511-7.
42. Ours TM, Kavuru MS, Schilz RJ, Richter JE. A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. Am J Gastroenterol 1999; 94: 3131-8.
43. Field SK, Sutherland LR. Does medical antireflux treatment improve asthma in asthmatics with gastroesophageal reflux: a critical review of the literature. Chest 1998; 87: 872-81.
44. Gibson PG, Henry RL, Coughlan JL. Gastrooesophageal reflux treatment for asthma in adults and children. Cochrane Database Syst Rev 2003; 1: no page numbers.
45. Tsugeno H, Mizuno M, Fujik S, et al. A proton-pump inhibitor, rabeprazole, improves ventilatory function in patients with asthma associated with gastroesophageal reflux. Scand J Gastroenterol 2003; 38: 456-61.
46. Littner MR, Ballard ED, Huang B, Samra NK. Lansoprazole for 24 weeks reduced asthma exacerbations and improves quality of life in subjects with symptoms of acid reflux - a multicenter, randomized, double-blind, placebo controlled trial. Am J Gastroenterol 2002; 97: S13.
47. Sontag SJ, O'Connell S, Khandelwal S, et al. Asthmatics with gastroesophageal reflux: long term results of a randomized trial of medical and surgical anti-reflux therapies. Am J Gastroenterol 2003; 98: 987-99.
48. Khoshoo V, Thao L, Haydel RM, et al. Role of gastroesophageal reflux in older children with persistent asthma. Chest 2003; 123: 1008-13.
49. Poe RH, Kalloy MC. Chronic cough and gastroesophageal reflux disease. Experience with specific therapy for diagnosis and treatment. Chest 2003; 123: 679-84.
50. Novitsky YW, Zawacki JK, Irwin RS, et al. Chronic cough due to gastroesophageal reflux disease. Efficacy of antireflux surGORy. Surg Endosc 2002; 16: 567-71.
51. Kiljander TO, Salomas ERM, Hietanen EK, et al. Chronic cough and gastro-oesophagal reflux: a double-blind placebo-controlled study with omeprazole. Eur Respir J 2000; 16: 633-8.